rifampin
- Product NDC
- 50090-5709
- 11-digit product format
- 500905709
- Labeler code
- 50090
- Product ID
- 50090-5709_37783510-9524-4bee-89d1-c96e36d6791a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifampin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA090034
- Marketing category
- ANDA
- Marketing start
- 2014-01-08
- Substance
- RIFAMPIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- rifampin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFAMPIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VJT6J7R4TR |
| Rxcui | 198202 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5709-0 | rifampin | 30 in 1 BOTTLE | CAPSULE | 30 | | 7 |
| 50090-5709-3 | rifampin | 60 in 1 BOTTLE | CAPSULE | 60 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5709 | RIFAMPIN CAPSULE [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230911_d53b6998-6e3b-4c6f-8465-2af6897d1efe.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5709-0 | 50090570900 | 30 CAPSULE in 1 BOTTLE (50090-5709-0) | 30 capsule | 2021-09-24 | 0000-00-00 | No | No | Current |
| 50090-5709-3 | 50090570903 | 60 CAPSULE in 1 BOTTLE (50090-5709-3) | 60 capsule | 2021-09-24 | 0000-00-00 | No | No | Current |